BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
124 results:

  • 1. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian cancer Centres.
    Pallocca M; Molineris I; Berrino E; Marcozzi B; Betti M; Levati L; D'Atri S; Menin C; Madonna G; Ghiorzo P; Bulgarelli J; Ferraresi V; Venesio T; Rodolfo M; Rivoltini L; Lanfrancone L; Ascierto PA; Mazzarella L; Pelicci PG; De Maria R; Ciliberto G; Medico E; Russo G
    J Transl Med; 2024 Jan; 22(1):29. PubMed ID: 38184610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
    Huang WK; Hsu HC; Yang TS; Lu CW; Pan YR; Wu CE; Chung WH; Hung SI; Yeh CN
    Eur J Cancer; 2023 Dec; 195():113286. PubMed ID: 37968194
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis.
    Zarin B; Nedaeinia R; Laher I; Manian M; Javanmard SH
    Tumour Biol; 2023; 45(1):111-126. PubMed ID: 37927290
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Concurrent PTEN and pdgfrb Alterations Characterize Storiform Collagenoma.
    Pakyari M; Mahadevan NR; Russell-Goldman E
    Am J Surg Pathol; 2024 Feb; 48(2):150-156. PubMed ID: 37899509
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel ANKRD26 and pdgfrb gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review.
    Fayiga FF; Reyes-Hadsall SC; Moreno BA; Oh KS; Brathwaite C; Duarte AM
    J Cutan Pathol; 2023 May; 50(5):425-429. PubMed ID: 36753059
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Familial multiple discoid fibromas is linked to a locus on chromosome 5 including the FNIP1 gene.
    van de Beek I; Glykofridis IE; Tanck MWT; Luijten MNH; Starink TM; Balk JA; Johannesma PC; Hennekam E; van den Hoff MJB; Gunst QD; Gille JJP; Polstra AM; Postmus PE; van Steensel MAM; Postma AV; Wolthuis RMF; Menko FH; Houweling AC; Waisfisz Q
    J Hum Genet; 2023 Apr; 68(4):273-279. PubMed ID: 36599954
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation.
    Kitz R; Leung O; Royer M
    J Cutan Pathol; 2023 Feb; 50(2):113-117. PubMed ID: 36059094
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of Potential Drug Therapy for Dermatofibrosarcoma Protuberans with Bioinformatics and Deep Learning Technology.
    Liu M; Yang F; Xu Y
    Curr Comput Aided Drug Des; 2022; 18(5):393-405. PubMed ID: 35975851
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Penttinen syndrome-associated pdgfrb Val665Ala variant causes aberrant constitutive STAT1 signalling.
    Nédélec A; Guérit EM; Dachy G; Lenglez S; Wong LS; Arts FA; Demoulin JB
    J Cell Mol Med; 2022 Jul; 26(14):3902-3912. PubMed ID: 35689379
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).
    Kamimura A; Nakamura Y; Takenouchi T; Matsushita S; Omodaka T; Yamamura K; Uchi H; Yoshikawa S; Yanagisawa H; Ito T; Kiyohara Y; Nakamura Y; Aoki M; Ishizuki S; Oashi K; Miyagawa T; Maeda T; Ogata D; Hatta N; Ohe S; Isei T; Takahashi A; Umeda Y; Yamaguchi B; Ishikawa M; Horimoto K; Fujsawa Y; Uehara J; Shibayama Y; Kiniwa Y; Kawahara Y; Matsuya T; Uhara H; Kato J; Nakamura Y; Murakami T; Namikawa K; Yoshino K; Funakoshi T; Takatsuka S; Matsui Y; Sasaki J; Koga H; Yokota K; Komori T; Fukushima S; Yamazaki N
    J Dermatol; 2022 Sep; 49(9):837-844. PubMed ID: 35510662
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy.
    Klein S; Quaas A; Noh KW; Cartolano M; Abedpour N; Mauch C; Quantius J; Reinhardt HC; Buettner R; Peifer M; Helbig D
    Clin Cancer Res; 2020 Nov; 26(21):5638-5645. PubMed ID: 32817080
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-pdgfrb fusion.
    Eissa SS; Clay MR; Santiago T; Wu G; Wang L; Shulkin BL; Picarsic J; Nichols KE; Campbell PK
    Blood Adv; 2020 Jul; 4(13):2991-2995. PubMed ID: 32609843
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pericyte dysfunction due to Shb gene deficiency increases B16F10 melanoma lung metastasis.
    He Q; Li X; He L; Li Y; Betsholtz C; Welsh M
    Int J Cancer; 2020 Nov; 147(9):2634-2644. PubMed ID: 32441314
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Myeloid neoplasm with the abnormality of pdgfrb gene secondary interstitial pneumonia: A case report.
    Liu G; Ouyang R; Chen P; Liu T; Zhou L; Shen C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):345-348. PubMed ID: 32386029
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways.
    Adam C; Fusi L; Weiss N; Goller SG; Meder K; Frings VG; Kneitz H; Goebeler M; Houben R; Schrama D; Schmidt M
    J Invest Dermatol; 2020 Dec; 140(12):2455-2465.e10. PubMed ID: 32376279
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Kosaki overgrowth syndrome: A novel pathogenic variant in pdgfrb and expansion of the phenotype including cerebrovascular complications.
    Foster A; Chalot B; Antoniadi T; Schaefer E; Keelagher R; Ryan G; Thomas Q; Philippe C; Bruel AL; Sorlin A; Thauvin-Robinet C; Bardou M; Luu M; Quenardelle V; Wolff V; Woodley J; Vabres P; Lim D; Igbokwe R; Joseph A; Walker H; Jester A; Ellenbogen J; Johnson D; Rooke B; Moss C; Cole T; Faivre L
    Clin Genet; 2020 Jul; 98(1):19-31. PubMed ID: 32291752
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma.
    Tiago M; Capparelli C; Erkes DA; Purwin TJ; Heilman SA; Berger AC; Davies MA; Aplin AE
    Br J Cancer; 2020 Mar; 122(6):789-800. PubMed ID: 31932756
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel
    Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
    Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
    Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pdgfr-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma.
    Bernat-Peguera A; Simón-Extremera P; da Silva-Diz V; López de Munain M; Díaz-Gil L; Penin RM; González-Suárez E; Pérez Sidelnikova D; Bermejo O; Viñals JM; Viñals F; Muñoz P
    Oncogene; 2019 Jun; 38(25):5021-5037. PubMed ID: 30874597
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.